Ocular Therapeutix, Inc. (OCUL): Price and Financial Metrics
OCUL Price/Volume Stats
| Current price | $8.78 | 52-week high | $11.77 |
| Prev. close | $8.92 | 52-week low | $2.14 |
| Day low | $8.57 | Volume | 797,600 |
| Day high | $8.99 | Avg. volume | 1,848,869 |
| 50-day MA | $9.90 | Dividend yield | N/A |
| 200-day MA | $8.08 | Market Cap | 1.38B |
OCUL Stock Price Chart Interactive Chart >
Ocular Therapeutix, Inc. (OCUL) Company Bio
Ocular Therapeutix is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. The company was founded in 2006 and is based in Bedford, Massachusetts.
OCUL Price Returns
| 1-mo | -22.30% |
| 3-mo | -3.62% |
| 6-mo | 51.51% |
| 1-year | 293.72% |
| 3-year | 34.66% |
| 5-year | 176.97% |
| YTD | 96.86% |
| 2023 | 58.72% |
| 2022 | -59.68% |
| 2021 | -66.33% |
| 2020 | 424.05% |
| 2019 | -0.75% |
Continue Researching OCUL
Want to do more research on Ocular Therapeutix Inc's stock and its price? Try the links below:Ocular Therapeutix Inc (OCUL) Stock Price | Nasdaq
Ocular Therapeutix Inc (OCUL) Stock Quote, History and News - Yahoo Finance
Ocular Therapeutix Inc (OCUL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...